
Is TEM (Tempus AI, Inc.) Halal or Haram?
Tempus AI demonstrates strong alignment with AAOIFI standards, comfortably passing all financial thresholds with a debt-to-market cap ratio of just 8.8%. The company's reliance on interest-bearing instruments is minimal, evidenced by an interest income -to-revenue ratio of only 0.99%, well below the 5% limit. With cash and securities comprising 8.1% of its market cap, the company maintains a compliant liquidity profile suitable for Shariah-conscious portfolios .
Price Chart (5D)
TEM — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-06-09 | 48.76 | 49.48 | 45.31 | 48.82 | 7.3M | +0.12% |
| 2026-06-08 | 47.36 | 48.61 | 46.18 | 48.59 | 4.8M | +2.60% |
| 2026-06-05 | 50.82 | 52.23 | 45.84 | 46.43 | 8.9M | -8.64% |
| 2026-06-04 | 46.90 | 53.97 | 46.69 | 52.26 | 13.9M | +11.43% |
| 2026-06-03 | 48.50 | 48.65 | 46.37 | 47.51 | 6.5M | -2.04% |
| 2026-06-02 | 51.50 | 52.00 | 49.44 | 49.62 | 6.4M | -3.65% |
| 2026-06-01 | 49.51 | 54.75 | 48.40 | 52.80 | 9.7M | +6.65% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for TEM
Business Activity
Permissible
Tempus AI passes the business activity screen as its core revenue comes from permissible healthcare technology, specifically molecular diagnostics, data licensing, and clinical trial matching services.
Debt / Market Cap
8.79%
Interest Income
0.99%
Cash & Securities
8.13%
About Tempus AI, Inc. (TEM)
Tempus AI operates at the intersection of healthcare and technology, focusing on precision medicine through extensive data analysis. Their core business revolves around providing next-generation sequencing diagnostics and molecular profiling to help physicians make real-time, data-driven decisions for patient care. Additionally, they license their vast library of de-identified clinical and molecular data to pharmaceutical companies to accelerate drug discovery and development.
For Muslim investors, Tempus AI is considered Halal under AAO IFI standards, having passed all four key screening metrics. The company’s business activities are inherently permissible, as they contribute to saving lives and advancing medical science without involvement in prohibited industries like alcohol or gambling. This 'clean' operational model makes it an attractive option for those seeking ethical exposure to the AI and biotech sectors.
Financially, the company maintains a very healthy balance sheet from an Islamic finance perspective. Its interest-bearing debt is low relative to its market capitalization (8.8%), and its income from interest is negligible at less than 1% of total revenue, ensuring that 'impure' income remains minimal. This low leverage reduces financial risk and aligns well with the principles of avoiding excessive Riba (interest).
Investors should continue to monitor the company's 'Insights' data licensing segment to ensure future contracts remain compliant, though current operations show no red flags. As Tempus grows, maintaining these low debt and liquidity ratios will be key to retaining its compliant status, but for now, it stands as a robust candidate for a Shariah-compliant portfolio.
TEM Key Financial Statistics
Revenue
$1.27B
Net Income
$-245.0M
EPS (Diluted)
$-1.41
Stock Price
53.71
Beta
5.23
52-Week Range
36.22-104.32
Total Debt
$815.7M
Total Equity
$491.3M
Current Ratio
3.13
TEM Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+83.4%
Prior year: $693.4M
Net Debt
$210.9M
Cash: $604.8M — Debt: $815.7M
R&D Spending
$146.1M
% of Revenue
11.5%
Frequently Asked Questions About TEM
Is TEM (Tempus AI, Inc.) stock halal to invest in?▾
What does Tempus AI, Inc. do?▾
What screening criteria were used for TEM?▾
Does TEM require income purification?▾
When was TEM last screened?▾
Disclaimer
This shariah compliance assessment for TEM (Tempus AI, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-02-25.